Differential MicroRNA-Signatures in Thyroid Cancer Subtypes

Abstract EN

Thyroid cancer is one of the most common endocrine cancers, with an increasing trend in the last few decades.

Although papillary thyroid cancer is the most frequent subtype compared with follicular or anaplastic thyroid cancer, it can dedifferentiate to a more aggressive phenotype, and the recurrence rate is high.

The cells of follicular adenomas and follicular carcinomas appear identical in cytology, making the preoperative diagnosis difficult.

On the other hand, anaplastic thyroid cancer poses a significant clinical challenge due to its aggressive nature with no effective therapeutic options.

In the past several years, the roles of genetic alterations of thyroid tumors have been documented, with a remarkable correlation between genotype and phenotype, indicating that distinct molecular changes are associated with a multistep tumorigenic process.

Besides mRNA expression profiles, small noncoding microRNA (miRNA) expression also showed critical functions for cell differentiation, proliferation, angiogenesis, and resistance to apoptosis and finally activating invasion and metastasis in cancer.

Several high-throughput sequencing studies demonstrate that miRNA expression signatures contribute clinically relevant information including types of thyroid cancer, tumor grade, and prognosis.

This review summarizes recent findings on miRNA signatures in thyroid cancer subtypes.